Patents
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
08/2005
08/04/2005WO2005070910A2 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
08/04/2005WO2005070889A1 Herbicidal amides
08/04/2005WO2005051917B1 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions
08/04/2005WO2005037199A3 Pyrazole derivatives as cannabinoid receptor modulators
08/04/2005WO2004075840A9 Selective non-steroidal glucocorticoid receptor modulators
08/04/2005WO2004008837A9 Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them
08/04/2005US20050171181 Histamine-3 receptor modulators
08/04/2005US20050171180 by targeting beta and gamma secretase enzyme decreases production of amyloid precursor protein; 5-Chloro-N-{2-ethyl-1-[1-(4-methoxybenzyl)-1H-pyrazol-5-yl]butyl}thiophene-2-sulfonamide; Alzheimer's Disease, Down's Syndrome, cognitive decline
08/04/2005US20050171179 1,3,5-trisubstituted 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
08/04/2005US20050171172 platelet derived growth factor receptor; anticarcinogenic; leukemia; specific kinase inhibitors; accurate targeting with limited inhibition of other pathways; reduced toxicity
08/04/2005US20050171171 colony-stimulating factor receptor (c- FMS)-like tyrosine kinase 3; anticarcinogenic; leukemia;specific kinase inhibitors; accurate targeting with limited inhibition of other pathways; reduced toxicity
08/04/2005US20050171164 5-substituted-alkylaminopyrazole derivatives as pesticides
08/04/2005US20050171136 Modulators of the glucocorticoid receptor and method
08/04/2005US20050171109 Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
08/04/2005US20050171097 aryl is nitrogen heterocycyl; highly effective at a low dose and excellent in safety; farm and garden pests; 2-(2-propenylthio)-4-(4-trifluoromethylphenyl)benzonitrile
08/04/2005US20050171065 NAALADas, N-Acetylated-Alpha-Linked-Acidic-Dipeptidase inhibitors; 5-phosphonomethyl-1,3-benzenedicarboxylic Acid; glutamate abnormalities, anticancer, antidiabetic agent, angiogenesis inhibitor, neuropathy, pain, compulsive disorders, prostate diseases, glaucoma
08/04/2005US20050166335 4,5-diamino-1,2-dimethyl-1,2-dihydropyrazol-3-one; oxidation dyes for human hair
08/03/2005EP1559709A1 Heterocycle-containing carboxylic acid derivative and drug containing the same
08/03/2005EP1558585A1 Neurologically-active compounds
08/03/2005EP1558582A1 Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
08/03/2005EP1558203A2 Hair treatment composition containing a styryl-pyrazole compound
08/03/2005CN1649885A Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such
08/03/2005CN1649830A Substituted aryl ketones
08/03/2005CN1649829A Novel florfenicol-type antibiotics
08/03/2005CN1649820A Compounds that modulate PPAR activity and methods for their preparation
08/03/2005CN1649582A Amino-methyl substituted tetracycline compounds
08/03/2005CN1213040C Serine protese inhibitors
08/03/2005CN1213038C Benzophenones as inhibitors of reverse transcriptase
08/03/2005CN1213025C 硫代酰胺衍生物 Thioamide derivatives
08/02/2005US6924251 herbicides.
08/02/2005CA2190087C Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic activities
07/2005
07/28/2005WO2005068432A1 Malononitrile compound as pesticides
07/28/2005WO2005068423A1 Malononitrile compound and use thereof
07/28/2005WO2005054246A3 Amine derivatives having a tyrosine-kinase-inhibiting effect
07/28/2005WO2005048948A3 Urea derivatives as kinase modulators
07/28/2005WO2004060306A3 Anti-inflammatory medicaments
07/28/2005US20050165237 Process for asymmetric intramolecular [3+2] cyclo-addition of hydrazones
07/28/2005US20050165074 inhibitors of protein tyrosine kinases, for preventing of cancer, cardiovascular disease, inflammation or multiple sclerosis
07/28/2005US20050165034 Novel heterocyclic derivatives of tripeptides and tripeptide mimetics; (+-)-2-[3-[(benzylsulfonyl)amino]-6-methyl-2-oxo-1 (2H)-pyridinyl]-N-[(4,5,6,7-tetrahydro-2H-indazole-5-yl]acetamide; anticoagulants
07/28/2005US20050165031 1-(4-(3-(Pyridin-4-yl)propoxy)phenyl)-3-(5-tert-butylisoxazol-3-yl)urea; inhibits protein tyrosine kinases or a specific kinase or kinase class; for for treating and preventing conditions and diseases such as cancer, hematologic malignancies, cardiovascular disease, inflammation or multiple sclerosis
07/28/2005US20050165024 Urea derivatives as kinase modulators
07/28/2005US20050165005 Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them
07/28/2005US20050164886 Herbicidal compositions
07/28/2005US20050164883 agronomically tolerable salts, isomers and enantiomers of those compounds, are suitable for use as herbicides
07/28/2005US20050164120 High photosensitivity, visible laser recording materials; comprised of novel squarylium compound metal complexes, free radical generators and monomers
07/28/2005CA2547703A1 Bicyclic pyrazolo-fused compounds as protein kinase modulators
07/28/2005CA2547696A1 Malononitrile compounds and use thereof
07/27/2005EP1557168A2 Biarylurea Derivatives
07/27/2005EP1556385A1 Heterocyclocarboxamide derivatives
07/27/2005EP1556359A1 Pyrazole derivatives and their use as therapeutic agents for hiv mediated diseases
07/27/2005EP1556059A1 Thrombopoietin mimetics
07/27/2005EP1556053A1 Antiinflammation agents
07/27/2005EP1556032A1 Agent for preventing or treating neuropathy
07/27/2005EP1047418B1 Inhibition of raf kinase using substituted heterocyclic ureas
07/27/2005CN1646518A 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers
07/27/2005CN1646494A Disubstituted pyrazolyl carboxanilides
07/27/2005CN1646488A Substituted aryl ketones
07/27/2005CN1646473A Novel curcumin analogues and uses thereof
07/26/2005US6921767 Such as (2-(4-(3-(1,4,5,6-Tetrahydropyrimidin-2-ylamino)prop oxy)phenyl) -cyclopropyl)acetic acid; for treating angiogenesis/osteoporosis/ humoral hypercalcemia/smooth muscle cell migration/atherosclerosis/arthritis
07/21/2005WO2005066164A1 Opioid receptor antagonists
07/21/2005WO2005066138A1 Substituted heterocyclic amides having a fungicidal effect
07/21/2005WO2005066136A1 Bicyclic derivatives as ppar modulators
07/21/2005WO2005066135A2 Pyrrole and pyrazole daao inhibitors
07/21/2005WO2005066126A1 Cb1 modulator compounds
07/21/2005WO2005065779A1 Calcitonin gene related peptide receptor antagonists
07/21/2005WO2005065681A1 N- hydroxy-3-(3-(1h-imidazol-2-yl)-phenyl)-acrylamide derivatives and related compounds as histone deacetylase (hdac) inhibitors for the treatment of cancer
07/21/2005WO2005042480A3 N-substituted pyrazolyl carboxanilides
07/21/2005WO2005013914A3 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
07/21/2005US20050159470 Histone deacetylase inhibitors
07/21/2005US20050159424 pharmaceutically-acceptable salts, prodrugs, solvates, isomers, and/or hydrates thereof, wherein Q is an optionally-substituted phenyl, pyridyl, pyridazinyl, pyrimidinyl, or pyrazinyl ring; R2 is alkyl or an amino group as defined herein; and Z is optionally-substituted oxadiazolyl or C( .dbd. O)NR6,
07/21/2005DE10359074A1 Pyrazolinole Pyrazolinole
07/21/2005DE10359026A1 Verfahren zur Herstellung von Tetrahydrogeranylaceton A process for preparing tetrahydrogeranylacetone
07/21/2005DE102004005317A1 Optisch aktive Carboxamide Optically active carboxamides
07/21/2005CA2551952A1 Pyrrole and pyrazole daao inhibitors
07/21/2005CA2549396A1 Cb1 modulator compounds
07/21/2005CA2549330A1 Calcitonin gene related peptide receptor antagonists
07/21/2005CA2549089A1 Opioid receptor antagonists
07/20/2005EP1554260A1 Aryloxyalkylamine derivatives as h3 receptor ligands
07/20/2005EP1554251A1 Process for making pyrazole compounds
07/20/2005EP1554239A2 Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists
07/20/2005EP1553985A2 Biphenyls and fluorenes as imaging agents in alzheimer's disease
07/20/2005EP1268396B1 Diphenyl ether compounds useful in therapy
07/20/2005EP1056717B1 Arylphenyl-substituted cyclic keto-enols
07/20/2005CN1643205A Aqueous liquid formulations of pyrazoline brighteners
07/20/2005CN1642926A Crystalline parecoxib sodium
07/20/2005CN1642922A Substituted indazoles with anti-cancer activity
07/20/2005CN1642921A 5-substituted-alkylaminopyrazole derivatives as pesticides
07/20/2005CN1642920A 5-substituted-alkylaminopyrazole derivatives as pesticides
07/20/2005CN1642919A Pyrazolines for use as pesticides
07/20/2005CN1642918A Novel hererocyclic compound and preparation thereof and medicine composition containing same and use thereof in medicine
07/20/2005CN1642425A Method of purifying a pesticide
07/20/2005CN1211367C Prostaglandin agonists and their use to treat bone disorders
07/19/2005US6919470 Aryl and heteroaryl sulfonates
07/19/2005US6919462 Using 1-aryl-3-cyano-5-aminopyrazole compound
07/19/2005US6919461 Anticancer agents; antiarthritic agents
07/19/2005US6919367 Substituted thioacetamides
07/19/2005US6919363 Central nervous system disorders; antiischemic agents; analgesics
07/19/2005US6919354 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
07/14/2005WO2005064008A1 Method and compositions for identifying anti-hiv therapeutic compounds
07/14/2005WO2005063765A1 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto